rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Kodiak Sciences Inc

KOD · Nasdaq

Health CareBiotechnologyJust started moving

KOD stood above a rising 150-day average in 48 of the last 52 weekly readings, including each of the last 3 weeks. It is 98.1% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
3 in a row
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$374.0M
Insider sales, 12 months
$4.4M
Officials’ trades on record
2
Institutions holding
189 (+13)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 48 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$302.6MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Chris Jacobs House: U.S. House ClerkNY27sold$1k–$15k8 Nov 2022filed 12 Dec 2022
Chris Jacobs House: U.S. House ClerkNY27bought$1k–$15k18 Jul 2022filed 9 Sep 2022

Insiders

Buy orders, 12 months9
Sale orders, 12 months2
Buyers · sellers5 · 1
WhoDidSharesTraded
Baker Bros. Advisors LpDirector, 10% ownerbought619at $84.2429 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought10,381at $84.2429 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought1,195at $85.4029 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought20,031at $85.4029 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought84at $85.8929 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought1,416at $85.8929 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought856at $61.2128 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought14,344at $61.2128 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought2,666at $61.6328 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought44,690at $61.6328 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought243at $62.9628 Sep 2026filed 30 Sep 2026
Baker Bros. Advisors LpDirector, 10% ownerbought4,067at $62.9628 Sep 2026filed 30 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders189+13 on the quarter
New · exited38 · 25
Reported value$2.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 202619,919,186$776.1M00.0%
BlackRock, Inc.added · filed 7 Aug 20264,135,355$161.1M+200,053+5.1%
STATE STREET CORPadded · filed 7 Aug 20262,419,417$94.3M+168,497+7.5%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 20262,316,014$90.2M+627,011+37.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,804,632$70.3M+87,556+5.1%
BRAIDWELL LPreduced · filed 14 Aug 20261,787,318$69.6M-31,347−1.7%
Jupiter Topco LLCnew · filed 14 Aug 20261,526,006$59.5M+1,526,006
RTW INVESTMENTS, LPunchanged · filed 14 Aug 20261,487,934$58.0M00.0%
Boxer Capital Management, LLCadded · filed 14 Aug 20261,477,600$57.6M+116,600+8.6%
TCG Crossover Management, LLCunchanged · filed 14 Aug 20261,445,538$56.3M00.0%
31 Mar 2023 – 30 Jun 2026
87136185Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

667, L.p. Company insiderDirector, 10% owner · last 29 Sep 20265 · 0
BAKER BROS. ADVISORS LP Company insiderDirector, 10% owner · last 29 Sep 202611 · 0
Baker Bros. Advisors (Gp) Llc Company insiderDirector, 10% owner · last 28 Sep 20268 · 0
Julian Baker Company insiderDirector, 10% owner · last 28 Sep 20267 · 0
Victor Perlroth Company insiderChairman and CEO · last 25 Sep 20260 · 2
John A. Borgeson Company insiderChief Financial Officer · last 15 Jul 20260 · 13
Bassil I. Dahiyat Company insiderDirector · last 30 Jun 20260 · 0
Charles A. Bancroft Company insiderDirector · last 30 Jun 20260 · 0
Felix Baker Company insiderDirector, 10% owner · last 30 Jun 202611 · 0
Richard S. Levy Company insiderDirector · last 30 Jun 20261 · 0
Robert Profusek Company insiderDirector · last 30 Jun 20261 · 0
Taiyin Yang Company insiderDirector · last 30 Jun 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-76.6%
Share count trendFY 2025 · to 19 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$209.9M
Free cash flowFY 2025 · to 31 Dec 2025−$136.5M

Analyst forecasts

No analyst forecasts yet.